FDA Approves Exblifep (cefepime/enmetazobactam) for the Treatment of Complicated Urinary Tract Infections
SAINT-LOUIS, France& WEILL AM RHEIN, Germany February 27, 2024 -- Allecra Therapeutics (“Allecra”), a biopharmaceutical company developing novel therapies to combat antibiotic resistance, announced today that the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 27, 2024 Category: Drugs & Pharmacology Source Type: news
Doxorubicin Ups Breast Cancer Risk in Hodgkin Lymphoma Doxorubicin Ups Breast Cancer Risk in Hodgkin Lymphoma
The findings may have implications for breast cancer surveillance among survivors of Hodgkin lymphoma.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 27, 2024 Category: Drugs & Pharmacology Tags: Hematology-Oncology Source Type: news
Safety Outcomes When “Switching” Between Biosimilars and Reference Products
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 27, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Delsam Pharma LLC - 657340 - 02/13/2024
CGMP/Finished Pharmaceuticals/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 27, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
EzriCare LLC - 658390 - 02/13/2024
CGMP/Finished Pharmaceuticals/Adulterated (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 27, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
